# Melatonin on Coronary Artery Calcification

> **NCT03966235** · PHASE4 · UNKNOWN · sponsor: **Chinese PLA General Hospital** · enrollment: 74 (estimated)

## Conditions studied

- Coronary Artery Calcification

## Interventions

- **DRUG:** Melatonin 3 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03966235
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-01
- **Primary completion:** 2021-06-01
- **Final completion:** 2021-06-01
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2019-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03966235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03966235, "Melatonin on Coronary Artery Calcification". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT03966235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*